The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 649, Issue 1-2, 2008, Pages 161-178

  Chakravarti, Dhrubajyoti ^a   Venugopal, Divya ^a   Mailander, Paula C ^a   Meza, Jane L ^b   Higginbotham, Sheila ^a   Cavalieri, Ercole L ^a   Rogan, Eleanor G ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

^b 984350 Nebraska Medical Center ^*  (United States)

Author keywords

H ras; Mutations; Polycyclic aromatic hydrocarbons; SENCAR mouse skin

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; DIBENZO[A,L]PYRENE; DNA GLYCOSYLTRANSFERASE; HETERODUPLEX; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENIC ACTIVITY; CONTROLLED STUDY; DNA ADDUCT; FEMALE; GENE SEQUENCE; MOUSE; MUTAGENESIS; MUTATION; NONHUMAN; PAPILLOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BASE SEQUENCE; BENZOPYRENES; CARCINOGENS; DNA ADDUCTS; FEMALE; GENES, RAS; MICE; MICE, INBRED SENCAR; MODELS, GENETIC; MUTATION; PAPILLOMA; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMERASE CHAIN REACTION; SKIN;

MUS;

EID: 36849019489     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.08.007     Document Type: Article

References (132)

1. Snook M.E., Sevenson R.F., Arrendale R.F., Higman H.C., and Chortyk O.T. The identification of high molecular weight polynuclear aromatic hydrocarbons in a biologically active fraction of cigarette smoke condensate. Beitrag. Tabacforsch. 9 (1977) 79-101
2. Mumford J.L., Li X., Hu F., Lu X.B., and Chuang J.C. Human exposure and dosimetry of polycyclic aromatic hydrocarbons in urine from Xuan Wei, China with high lung cancer mortality associated with exposure to unvented coal smoke. Carcinogenesis 16 (1995) 3031-3036
3. Yu S., and Campiglia A.D. Direct determination of dibenzo[a,l]pyrene and its four dibenzopyrene isomers in water samples by solid-liquid extraction and laser-excited time-resolved Shpol'skii spectrometry. Anal. Chem. 77 (2005) 1440-1447
4. Everall J.D., and Dowd P.M. Influence of environmental factors excluding ultra violet radiation on the incidence of skin cancer. Bull. Cancer 65 (1978) 241-247
5. Hoffmann D., and Hecht S.S. Advances in tobacco carcinogenesis. In: Cooper C.S., and Grover P.L. (Eds). Chemical Carcinogenesis and Mutagenesis I (1990), Springer-Verlag, Berlin 63-102
6. Hecht S.S. Tobacco smoke carcinogens and breast cancer. Environ. Mol. Mutagen. 39 (2002) 119-126
7. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res. 49 (1989) 4682-4689
8. van der Schroeff J.G., Evers L.M., Boot A.J., and Bos J.L. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J. Invest. Dermatol. 94 (1990) 423-425
9. Barbacid M. Ras oncogenes: their role in neoplasia. Eur. J. Clin. Invest. 20 (1990) 225-235
10. Grendys Jr. E.C., Barnes W.A., Weitzel J., Sparkowski J., and Schlegel R. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma. Gynecol. Oncol. 65 (1997) 343-347
11. Shiraishi T., Muneyuki T., Fukutome K., Ito H., Kotake T., Watanabe M., and Yatani R. Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations. Anticancer Res. 18 (1998) 2789-2792
12. Esapa C.T., Johnson S.J., Kendall-Taylor P., Lennard T.W., and Harris P.E. Prevalence of Ras mutations in thyroid neoplasia. Clin. Endocrinol. (Oxf) 50 (1999) 529-535
13. Semczuk A., Schneider-Stock R., Berbec H., Marzec B., Jakowicki J.A., and Roessner A. K-ras exon 2 point mutations in human endometrial cancer. Cancer Lett. 164 (2001) 207-212
14. Colapietro A.M., Goodell A.L., and Smart R.C. Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels. Carcinogenesis 14 (1993) 2289-2295
15. DiGiovanni J., Beltran L., Rupp A., Harvey R.G., and Gill R.D. Further analysis of c-Ha-ras mutations in papillomas initiated by several polycyclic aromatic hydrocarbons and papillomas from uninitiated, promoter-treated skin in SENCAR mice. Mol. Carcinog. 8 (1993) 272-279
16. Chakravarti D., Pelling J.C., Cavalieri E.L., and Rogan E.G. Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 10422-10426
17. Vahakangas K.H., Bennett W.P., Castren K., Welsh J.A., Khan M.A., Blomeke B., Alavanja M.C., and Harris C.C. p53 and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res. 61 (2001) 4350-4356
18. Li D., Firozi P.F., Zhang W., Shen J., DiGiovanni J., Lau S., Evans D., Friess H., Hassan M., and Abbruzzese J.L. DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer. Mutat Res. 513 (2002) 37-48
19. Cavalieri E.L., and Rogan E.G. Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 25 (1995) 677-688
20. Paules R.S., Cordeiro-Stone M., Mass M.J., Poirier M.C., Yuspa S.H., and Kaufman D.G. Benzo[a]pyrene diol epoxide I binds to DNA at replication forks. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 2176-2180
21. Devanesan P.D., RamaKrishna N.V., Padmavathi N.S., Higginbotham S., Rogan E.G., Cavalieri E.L., Marsch G.A., Jankowiak R., and Small G.J. Identification and quantitation of 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6 (1993) 364-371
22. Chen L., Devanesan P.D., Higginbotham S., Ariese F., Jankowiak R., Small G.J., Rogan E.G., and Cavalieri E.L. Expanded analysis of benzo[a]pyrene-DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation. Chem. Res. Toxicol. 9 (1996) 897-903
23. Cavalieri E.L., Rogan E.G., Li K.M., Todorovic R., Ariese F., Jankowiak R., Grubor N., and Small G.J. Identification and quantification of the depurinating adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]P. Chem. Res. Toxicol. 18 (2005) 976-983
24. Todorovic R., Devanesan P., Rogan E.G., and Cavalieri E.L. Identification and quantification of stable DNA adducts formed from dibenzo[a,l]pyrene or its metabolites in vitro and in mouse skin and rat mammary gland. Chem. Res. Toxicol. 18 (2005) 984-990
25. Lobanenkov V.V., Plumb M., Goodwin G.H., and Grover P.L. The effect of neighbouring bases on G-specific DNA cleavage mediated by treatment with the anti-diol epoxide of benzo[a]pyrene in vitro. Carcinogenesis 7 (1986) 1689-1695
26. Reardon D.B., Bigger C.A., Strandberg J., Yagi H., Jerina D.M., and Dipple A. Sequence selectivity in the reaction of optically active hydrocarbon dihydrodiol epoxides with rat H-ras DNA [letter]. Chem. Res. Toxicol. 2 (1989) 12-14
27. Rill R.L., and Marsch G.A. Sequence preferences of covalent DNA binding by anti-(+)- and anti-(-)-benzo[a]pyrene diol epoxides. Biochemistry 29 (1990) 6050-6058
28. Dittrich K.A., and Krugh T.R. Mapping of (+/-)-anti-benzo[a]pyrene diol epoxide adducts to human c-Ha-ras1 protooncogene. Chem. Res. Toxicol. 4 (1991) 277-281
29. Hruszkewycz A.M., Canella K.A., Peltonen K., Kotrappa L., and Dipple A. DNA polymerase action on benzo[a]pyrene-DNA adducts. Carcinogenesis 13 (1992) 2347-2352
30. Bigger C.A., Cheh A., Latif F., Fishel R., Canella K.A., Stafford G.A., Yagi H., Jerina D.M., and Dipple A. DNA strand breaks induced by configurationally isomeric hydrocarbon diol epoxides. Drug Metab. Rev. 26 (1994) 287-299
31. Chakravarti D., Cavalieri E.L., and Rogan E.G. Linear amplification mapping of polycyclic aromatic hydrocarbon-reactive sequences in H-ras gene. DNA Cell Biol. 17 (1998) 529-539
32. Chakravarti D. Polycyclic aromatic compounds mapping. In: Meyers R.A. (Ed). Encyclopedia of Analytical Chemistry: Instrumentation and Application (2000), John Wiley & Sons, Ltd., England 5144-5159
33. Slaga T.J., Bowden G.T., Shapas B.G., and Boutwell R.K. Macromolecular synthesis following a single application of polycyclic hydrocarbons used as initiators of mouse skin tumorigenesis. Cancer Res. 34 (1974) 771-777
34. Stewart B.W. Generation and persistence of carcinogen-induced repair intermediates in rat liver DNA in vivo. Cancer Res. 41 (1981) 3238-3243
35. Sawyer T.W., Gill R.D., Smith-Oliver T., Butterworth B.E., and DiGiovanni J. Measurement of unscheduled DNA synthesis in primary cultures of adult mouse epidermal keratinocytes. Carcinogenesis 9 (1988) 1197-1202
36. Gill R.D., Butterworth B.E., Nettikumara A.N., and DiGiovanni J. Relationship between DNA adduct formation and unscheduled DNA synthesis (UDS) in cultured mouse epidermal keratinocytes. Environ. Mol. Mutagen. 18 (1991) 200-206
37. Li R., Waga S., Hannon G.J., Beach D., and Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371 (1994) 534-537
38. Braithwaite E., Wu X., and Wang Z. Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro. Carcinogenesis 19 (1998) 1239-1246
39. Khan G.A., and Chakravarti D. Imbalanced induction of short-patch base excision repair genes in dibenzo[a,l]pyrene-treated mouse skin and estradiol-3,4-quinone-treated rat mammary gland is associated with XRCC1 insufficiency. Proc. Am. Assoc. Cancer Res. 46 (2005) 719
40. Wei D., Maher V.M., and McCormick J.J. Site-specific rates of excision repair of benzo[a]pyrene diol epoxide adducts in the hypoxanthine phosphoribosyltransferase gene of human fibroblasts: correlation with mutation spectra. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2204-2208
41. Mukherjee J.J., Gupta S.K., Kumar S., and Sikka H.C. Effects of cadmium(II) on (+/-)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide-induced DNA damage response in human fibroblasts and DNA repair: a possible mechanism of cadmium's cogenotoxicity. Chem. Res. Toxicol. 17 (2004) 287-293
42. Chakravarti D., Badawi A.F., Venugopal D., Meza J.L., Crandall L.Z., Rogan E.G., and Cavalieri E.L. Improved measurement of dibenzo[a,l]pyrene-induced abasic sites by the aldehyde-reactive probe assay. Mutat. Res. 588 (2005) 158-165
43. Chakravarti D., Mailander P., Franzen J., Higginbotham S., Cavalieri E.L., and Rogan E.G. Detection of dibenzo[a,l]pyrene-induced H-ras codon 61 mutant genes in preneoplastic SENCAR mouse skin using a new PCR-RFLP method. Oncogene 16 (1998) 3203-3210
44. Chakravarti D., Mailander P.C., Cavalieri E.L., and Rogan E.G. Evidence that error-prone DNA repair converts dibenzo[a,l]pyrene-induced depurinating lesions into mutations: formation, clonal proliferation and regression of initiated cells carrying H-ras oncogene mutations in early preneoplasia. Mutat. Res. 456 (2000) 17-32
45. Watanabe M., Maher V.M., and McCormick J.J. Excision repair of UV- or benzo[a]pyrene diol epoxide-induced lesions in xeroderma pigmentosum variant cells is 'error free'. Mutat. Res. 146 (1985) 285-294
46. Choi D.J., Roth R.B., Liu T., Geacintov N.E., and Scicchitano D.A. Incorrect base insertion and prematurely terminated transcripts during T7 RNA polymerase transcription elongation past benzo[a]pyrenediol epoxide-modified DNA. J. Mol. Biol. 264 (1996) 213-219
47. Maher V.M., and McCormick J.J. Role of DNA lesions and repair in the transformation of human cells. In: Grunberger D., and Groff S.P. (Eds). Mechanisms of Cellular Transformation by Carcinogenic agents (1987), Pergamon Press, New York 135-149
48. Kaufmann W.K. Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer Metastasis Rev. 14 (1995) 31-41
49. Moriya M., Spiegel S., Fernandes A., Amin S., Liu T., Geacintov N., and Grollman A.P. Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2′-deoxyguanosine DNA adducts: marked effects of host cell, sequence context, and chirality. Biochemistry 35 (1996) 16646-16651
50. McGregor W.G., Wei D., Chen R.H., Maher V.M., and McCormick J.J. Relationship between adduct formation, rates of excision repair and the cytotoxic and mutagenic effects of structurally-related polycyclic aromatic carcinogens. Mutat. Res. 376 (1997) 143-152
51. Zhang Y., Yuan F., Wu X., Rechkoblit O., Taylor J.S., Geacintov N.E., and Wang Z. Error-prone lesion bypass by human DNA polymerase eta. Nucleic Acids Res. 28 (2000) 4717-4724
52. Zhang Y., Yuan F., Wu X., Wang M., Rechkoblit O., Taylor J.S., Geacintov N.E., and Wang Z. Error-free and error-prone lesion bypass by human DNA polymerase kappa in vitro. Nucleic Acids Res. 28 (2000) 4138-4146
53. Perlow R.A., and Broyde S. Evading the proofreading machinery of a replicative DNA polymerase: induction of a mutation by an environmental carcinogen. J. Mol. Biol. 309 (2001) 519-536
54. Perlow R.A., Kolbanovskii A., Hingerty B.E., Geacintov N.E., Broyde S., and Scicchitano D.A. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner. J. Mol. Biol. 321 (2002) 29-47
55. Simhadri S., Kramata P., Zajc B., Sayer J.M., Jerina D.M., Hinkle D.C., and Wei C.S. Benzo[a]pyrene diol epoxide-deoxyguanosine adducts are accurately bypassed by yeast DNA polymerase zeta in vitro. Mutat. Res. 508 (2002) 137-145
56. Schinecker T.M., Perlow R.A., Broyde S., Geacintov N.E., and Scicchitano D.A. Human RNA polymerase II is partially blocked by DNA adducts derived from tumorigenic benzo[c]phenanthrene diol epoxides: relating biological consequences to conformational preferences. Nucleic Acids Res. 31 (2003) 6004-6015
57. 2-dG DNA adducts in yeast cells. Nucleic Acids Res. 34 (2006) 417-425
58. Nelson M.A., Futscher B.W., Kinsella T., Wymer J., and Bowden G.T. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6398-6402 (published erratum appears in Proc. Natl. Acad. Sci. U.S.A. 90(January (2)) (1993) 781)
59. Finch J.S., Albino H.E., and Bowden G.T. Quantitation of early clonal expansion of two mutant 61st codon c-Ha- ras alleles in DMBA/TPA treated mouse skin by nested PCR/RFLP. Carcinogenesis 17 (1996) 2551-2557
60. Melendez-Colon V.J., Smith C.A., Seidel A., Luch A., Platt K.L., and Baird W.M. Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides. Proc. Natl. Acad Sci. U.S.A. 94 (1997) 13542-13547
61. Tang M.S., Vulimiri S.V., Viaje A., Chen J.X., Bilolikar D.S., Morris R.J., Harvey R.G., Slaga T.J., and DiGiovanni J. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras. Cancer Res. 60 (2000) 5688-5695
62. Willumsen B.M., Papageorge A.G., Kung H.F., Bekesi E., Robins T., Johnsen M., Vass W.C., and Lowy D.R. Mutational analysis of a ras catalytic domain. Mol. Cell Biol. 6 (1986) 2646-2654
63. Sukumar S., and Barbacid M. Specific patterns of oncogene activation in transplacentally induced tumors. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 718-722
64. Karen J., Wang Y., Javaherian A., Vaccariello M., Fusenig N.E., and Garlick J.A. 12-O-tetradecanoylphorbol-13-acetate induces clonal expansion of potentially malignant keratinocytes in a tissue model of early neoplastic progression. Cancer Res. 59 (1999) 474-481
65. Yamakage K., Omori Y., Zaidan-Dagli M.L., Cros M.P., and Yamasaki H. Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted. J. Invest. Dermatol. 114 (2000) 289-294
66. Kunkel T.A. The mutational specificity of DNA polymerase β during in vitro DNA synthesis. Production of frameshift, base substitution, and deletion mutations. J. Biol. Chem. 260 (1985) 5787-5796
67. Thomas D.C., Roberts J.D., Sabatino R.D., Myers T.W., Tan C.K., Downey K.M., So A.G., Bambara R.A., and Kunkel T.A. Fidelity of mammalian DNA replication and replicative DNA polymerases. Biochemistry 30 (1991) 11751-11759
68. Chary P., and Lloyd R.S. In vitro replication by prokaryotic and eukaryotic polymerases on DNA templates containing site-specific and stereospecific benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide adducts. Nucleic Acids Res. 23 (1995) 1398-1405
69. 6 at the second position of N-ras codon 61. J. Biol. Chem. 270 (1995) 4990-5000
70. Lavrukhin O.V., and Lloyd R.S. Mutagenic replication in a human cell extract of DNAs containing site-specific and stereospecific benzo(a)pyrene-7,8-diol-9,10-epoxide DNA adducts placed on the leading and lagging strands. Cancer Res. 58 (1998) 887-891
71. Solhaug A., Refsnes M., Lag M., Schwarze P.E., Husoy T., and Holme J.A. Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells. Carcinogenesis 25 (2004) 809-819
72. Huc L., Rissel M., Solhaug A., Tekpli X., Gorria M., Torriglia A., Holme J.A., Dimanche-Boitrel M.T., and Lagadic-Gossmann D. Multiple apoptotic pathways induced by p53-dependent acidification in benzo[a]pyrene-exposed hepatic F258 cells. J. Cell Physiol. 208 (2006) 527-537
73. Stout G.J., Oosten M., Acherrat F.Z., Wit J., Vermeij W.P., Mullenders L.H., Gruijl F.R., and Backendorf C. Selective DNA damage responses in murine Xpa(-/-), Xpc(-/-) and Csb(-/-) keratinocyte cultures. DNA Repair (Amst.) 4 (2005) 1337-1344
74. Khan G.A., Bhattacharya G., Mailander P.C., Meza J.L., Hansen L.A., and Chakravarti D. Harvey-ras gene expression and epidermal cell proliferation in dibenzo[a,l]pyrene-treated early preneoplastic SENCAR mouse skin. J. Invest. Dermatol. 125 (2005) 567-574
75. Albert R.E., Miller M.L., Cody T., Andringa A., Shukla R., and Baxter C.S. Benzo[a]pyrene-induced skin damage and tumor promotion in the mouse. Carcinogenesis 12 (1991) 1273-1280
76. Corominas M., Leon J., Kamino H., Cruz-Alvarez M., Novick S.C., and Pellicer A. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model. Oncogene 6 (1991) 645-651
77. Zhang Y., Yuan F., Wu X., and Wang Z. Preferential incorporation of G opposite template T by the low-fidelity human DNA polymerase iota. Mol. Cell Biol. 20 (2000) 7099-7108
78. Sobol R.W., Watson D.E., Nakamura J., Yakes F.M., Hou E., Horton J.K., Ladapo J., Van Houten B., Swenberg J.A., Tindall K.R., Samson L.D., and Wilson S.H. Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6860-6865
79. Seo K.Y., Jelinsky S.A., and Loechler E.L. Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens. Mutat. Res. 463 (2000) 215-246
80. Yan S.F., Wu M., Geacintov N.E., and Broyde S. Altering DNA polymerase incorporation fidelity by distorting the dNTP binding pocket with a bulky carcinogen-damaged template. Biochemistry 43 (2004) 7750-7765
81. 2-dG adducts by human DNA polymerases eta and kappa. Mutat. Res. 510 (2002) 23-35
82. 6-dA lesions catalyzed by DNA bypass polymerases. J. Biol. Chem. 277 (2002) 30488-30494
83. Andreasen E. Cyclic changes in the skin of the mouse. Acta Pathol. Scand. 32 (1953) 157-164
84. Morris R.J., Coulter K., Tryson K., and Steinberg S.R. Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling. Cancer Res. 57 (1997) 3436-3443
85. Fischer W.H., and Lutz W.K. Correlation of individual papilloma latency time with DNA adducts, 8-hydroxy-2′-deoxyguanosine, and the rate of DNA synthesis in the epidermis of mice treated with 7,12-dimethylbenz[a]anthracene. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 5900-5904
86. Rogan E.G., Devanesan P.D., RamaKrishna N.V., Higginbotham S., Padmavathi N.S., Chapman K., Cavalieri E.L., Jeong H., Jankowiak R., and Small G.J. Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6 (1993) 356-363
87. Talaska G., Jaeger M., Reilman R., Collins T., and Warshawsky D. Chronic, topical exposure to benzo[a]pyrene induces relatively high steady-state levels of DNA adducts in target tissues and alters kinetics of adduct loss. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7789-7793
88. de Vries A., van Oostrom C.T., Dortant P.M., Beems R.B., van Kreijl C.F., Capel P.J., and van Steeg H. Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice. Mol. Carcinog. 19 (1997) 46-53
89. de Vries A., Dolle M.E., Broekhof J.L., Muller J.J., Kroese E.D., van Kreijl C.F., Capel P.J., Vijg J., and van Steeg H. Induction of DNA adducts and mutations in spleen, liver and lung of XPA- deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development. Carcinogenesis 18 (1997) 2327-2332
90. Wijnhoven S.W., Kool H.J., van Oostrom C.T., Beems R.B., Mullenders L.H., van Zeeland A.A., van der Horst G.T., Vrieling H., and van Steeg H. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice. Cancer Res. 60 (2000) 5681-5687
91. Gill H.S., Kole P.L., Wiley J.C., Li K.M., Higginbotham S., Rogan E.G., and Cavalieri E.L. Synthesis and tumor-initiating activity in mouse skin of dibenzo[a,l]pyrene syn- and anti-fjord-region diolepoxides. Carcinogenesis 15 (1994) 2455-2460
92. Hanson A.A., Li K.M., Lin C.H., Jankowiak R., Small G.J., Rogan E.G., and Cavalieri E.L. Synthesis and structure determination of 6-methylbenzo[a]pyrene-deoxyribonucleoside adducts and their identification and quantitation in vitro and in mouse skin. Chem. Biol. Interact. 128 (2000) 65-90
93. NIH Guidelines for the Laboratory Use of Chemical Carcinogens (1981), US Government Printing Office, Washington, DC
94. Higginbotham S., RamaKrishna N.V., Johansson S.L., Rogan E.G., and Cavalieri E.L. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis 14 (1993) 875-878
95. Sun Y., Hegamyer G., Cheng Y.J., Hildesheim A., Chen J.Y., Chen I.H., Cao Y., Yao K.T., and Colburn N.H. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6516-6520
96. Chakravarti D., Mailander P.C., Li K.-M., Higginbotham S., Zhang H.L., Gross M.L., Meza J.L., Cavalieri E.L., and Rogan E.G. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 20 (2001) 7945-7953
97. Mailander P.C., Khan G.A., Meza J.L., Higginbotham S., and Chakravarti D. Induction of abundant A.T to G.C mutations by erroneous repair of estrogen-induced depurinated DNA in the mammary gland of ACI rats. J. Steroid Biochem. Mol. Biol. 101 (2006) 205-215
98. Fromenty B., Demeilliers C., Mansouri A., and Pessayre D. Escherichia coli exonuclease III enhances long PCR amplification of damaged DNA templates. Nucleic Acids Res. 28 (2000) e50
99. Mahadevan B., Dashwood W.M., Luch A., Pecaj A., Doehmer J., Seidel A., Pereira C., and Baird W.M. Mutations induced by (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells. Environ. Mol. Mutagen. 41 (2003) 131-139
100. Stevens C.W., Manoharan T.H., and Fahl W.E. Characterization of mutagen-activated cellular oncogenes that confer anchorage independence to human fibroblasts and tumorigenicity to NIH 3T3 cells: sequence analysis of an enzymatically amplified mutant HRAS allele. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 3875-3879
101. Seo K.Y., Nagalingam A., Tiffany M., and Loechler E.L. Mutagenesis studies with four stereoisomeric N2-dG benzo[a]pyrene adducts in the identical 5′-CGC sequence used in NMR studies: G → T mutations dominate in each case. Mutagenesis 20 (2005) 441-448
102. Wei S.J., Chang R.L., Hennig E., Cui X.X., Merkler K.A., Wong C.Q., Yagi H., Jerina D.M., and Conney A.H. Mutagenic selectivity at the HPRT locus in V-79 cells: comparison of mutations caused by bay-region benzo[a]pyrene 7,8-diol-9,-10-epoxide enantiomers with high and low carcinogenic activity. Carcinogenesis 15 (1994) 1729-1735
103. Schiltz M., Cui X.X., Lu Y.P., Yagi H., Jerina D.M., Zdzienicka M.Z., Chang R.L., Conney A.H., and Wei S.J. Characterization of the mutational profile of (+)-7R,8S-dihydroxy-9S, 10R-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene at the hypoxanthine (guanine) phosphoribosyltransferase gene in repair-deficient Chinese hamster V-H1 cells. Carcinogenesis 20 (1999) 2279-2286
104. Yang H., Mazur-Melnyk M., de Boer J.G., and Glickman B.W. A comparison of mutational specificity of mutations induced by S9-activated B[a]P and benzo[a]pyrene-7,8-diol-9,10-epoxide at the endogenous aprt gene in CHO cells. Mutat. Res. 423 (1999) 23-32
105. Conney A.H., Chang R.L., Cui X.X., Schiltz M., Yagi H., Jerina D.M., and Wei S.J. Dose-dependent differences in the profile of mutations induced by carcinogenic (R,S,S,R) bay- and fjord-region diol epoxides of polycyclic aromatic hydrocarbons. Adv. Exp. Med. Biol. 500 (2001) 697-707
106. Wei S.J., Chang R.L., Bhachech N., Cui X.X., Merkler K.A., Wong C.Q., Hennig E., Yagi H., Jerina D.M., and Conney A.H. Dose-dependent differences in the profile of mutations induced by (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V-79 cells. Cancer Res. 53 (1993) 3294-3301
107. 2-dG adduct of (+)-anti-B[a]PDE shows a dramatically different mutagenic specificity (predominantly, G → A) in a 5′-CGT-3′ sequence context. Biochemistry 36 (1997) 10256-10261
108. Yang J.L., Maher V.M., and McCormick J.J. Kinds of mutations formed when a shuttle vector containing adducts of benzo[a]pyrene-7,8-diol-9,10-epoxide replicates in COS7 cells. Mol. Cell Biol. 7 (1987) 1267-1270
109. Skopek T.R., Kort K.L., Marino D.R., Mittal L.V., Umbenhauer D.R., Laws G.M., and Adams S.P. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice. Environ. Mol. Mutagen. 28 (1996) 376-384
110. Roilides E., Gielen J.E., Tuteja N., Levine A.S., and Dixon K. Mutational specificity of benzo[a]pyrene diolepoxide in monkey cells. Mutat. Res. 198 (1988) 199-206
111. Miller M.L., Vasunia K., Talaska G., Andringa A., de Boer J., and Dixon K. The tumor promoter TPA enhances benzo[a]pyrene and benzo[a]pyrene diolepoxide mutagenesis in Big Blue mouse skin. Environ. Mol. Mutagen. 35 (2000) 319-327
112. Frenkel K., Wei L., and Wei H. 7,12-Dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radic. Biol. Med. 19 (1995) 373-380
113. Kensler T.W., Egner P.A., Moore K.G., Taffe B.G., Twerdok L.E., and Trush M.A. Role of inflammatory cells in the metabolic activation of polycyclic aromatic hydrocarbons in mouse skin. Toxicol. Appl. Pharmacol. 90 (1987) 337-346
114. Keohavong P., DeMichele M.A., Melacrinos A.C., Landreneau R.J., Weyant R.J., and Siegfried J.M. Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin. Cancer Res. 2 (1996) 411-418
115. Prahalad A.K., Ross J.A., Nelson G.B., Roop B.C., King L.C., Nesnow S., and Mass M.J. Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis 18 (1997) 1955-1963
116. Nesnow S., Ross J.A., Mass M.J., and Stoner G.D. Mechanistic relationships between DNA adducts, oncogene mutations, and lung tumorigenesis in strain A mice. Exp. Lung Res. 24 (1998) 395-405
117. Ralston S.L., Seidel A., Luch A., Platt K.L., and Baird W.M. Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti(11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. Carcinogenesis 16 (1995) 2899-2907
118. Yoon J.H., Besaratinia A., Feng Z., Tang M.S., Amin S., Luch A., and Pfeifer G.P. DNA damage, repair, and mutation induction by (+)-syn and (-)-anti-dibenzo[a,l]pyrene-11,12-diol-13,14-epoxides in mouse cells. Cancer Res. 64 (2004) 7321-7328
119. Cheng S.C., Prakash A.S., Pigott M.A., Hilton B.D., Lee H., Harvey R.G., and Dipple A. A metabolite of the carcinogen 7,12-dimethylbenz[a]anthracene that reacts predominantly with adenine residues in DNA. Carcinogenesis 9 (1988) 1721-1723
120. Balmain A., Ramsden M., Bowden G.T., and Smith J. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307 (1984) 658-660
121. Fujiki H., Suganuma M., Yoshizawa S., Kanazawa H., Sugimura T., Manam S., Kahn S.M., Jiang W., Hoshina S., and Weinstein I.B. Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters. Mol. Carcinog. 2 (1989) 184-187
122. Brown K., Buchmann A., and Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 538-542
123. Megosh L., Halpern M., Farkash E., and O'Brien T.G. Analysis of ras gene mutational spectra in epidermal papillomas from K6/ODC transgenic mice. Mol. Carcinog. 22 (1998) 145-149
124. Chen J.X., Pao A., Zheng Y., Ye X., Kisleyou A.S., Morris R., Slaga T.J., Harvey R.G., and Tang M.S. Sequence preference of 7,12-dimethylbenz[a]anthracene-syn-diol epoxide-DNA binding in the mouse H-ras gene detected by UvrABC nucleases. Biochemistry 35 (1996) 9594-9602
125. Cavalieri E.L., and Rogan E.G. Mechanisms of tumor initiation by polycyclic aromatic hydrocarbons in mammals. In: Neilson A.H. (Ed). The Handbook of Environmental Chemistry (1998), Springer-Verlag, Heidelberg 81-117
126. Gorelick N.J., Andrews J.L., Gu M., and Glickman B.W. Mutational spectra in the lacl gene in skin from 7,12-dimethylbenz[a]anthracene-treated and untreated transgenic mice. Mol. Carcinog. 14 (1995) 53-62
127. Manjanatha M.G., Shelton S.D., Culp S.J., Blankenship L.R., and Casciano D.A. DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue rats treated with 7,12-dimethylbenz[a]anthracene. Carcinogenesis 21 (2000) 265-273
128. Mailander P.C., Meza J.L., Higginbotham S., and Chakravarti D. Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J. Steroid Biochem. Mol. Biol. 101 (2006) 204-215
129. Geacintov N.E., Shahbaz M., Ibanez V., Moussaoui K., and Harvey R.G. Base-sequence dependence of noncovalent complex formation and reactivity of benzo[a]pyrene diol epoxide with polynucleotides. Biochemistry 27 (1988) 8380-8387
130. Strauss B.S. The 'A rule' of mutagen specificity: a consequence of DNA polymerase bypass of non-instructional lesions?. Bioessays 13 (1991) 79-84
131. Shibutani S., Takeshita M., and Grollman A.P. Translesional synthesis on DNA templates containing a single abasic site. A mechanistic study of the "A rule". J. Biol. Chem. 272 (1997) 13916-13922
132. Petersen L.N., Orren D.K., and Bohr V.A. Gene-specific and strand-specific DNA repair in the G1 and G2 phases of the cell cycle. Mol. Cell Biol. 15 (1995) 3731-3737